We are live on
!
Find out more
BC
Bruce & Co Portfolio holdings
AUM
$350M
1-Year Est. Return
33.5%
This Fund
S&P 500
This Quarter
Est. Return
-3.04%
1 Year Est. Return
+33.5%
3 Year Est. Return
+65.72%
5 Year Est. Return
+73.85%
10 Year Est. Return
+249.08%
AUM
$356M
AUM Growth
-$10.4M
(-2.8%)
Cap. Flow
-$15.9M
Cap. Flow
% of AUM
-4.47%
Top 10 Holdings %
Top 10 Hldgs %
68.91%
Holding
37
New
–
Increased
2
Reduced
2
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Caribou Biosciences
CRBU
|
+$449K |
| 2 |
LVTX
LAVA Therapeutics
LVTX
|
+$185K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$871K |
| 2 |
AT&T
T
|
+$170K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.61% |
| 2 | Utilities | 29.35% |
| 3 | Industrials | 13.26% |
| 4 | Communication Services | 5.9% |
| 5 | Financials | 5.2% |
Similar funds
RFS
WMP
PCM
SA
MC
KFG
LAS
GAA
Bruce & Co's Q2 2023 Portfolio in Review
As of Q2 2023, Bruce & Co held 37 positions worth $356M, down 2.8% from $367M the previous quarter. Its ten largest holdings account for 69% of the portfolio.
Bruce & Co withdrew a net $15.9M in Q2 2023, reducing 2 holdings. Its largest reduction was Apple, cutting an estimated $871K.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 36% a quarter earlier, followed by Utilities and Industrials.
Against the trend, Bruce & Co added an estimated $449K to Caribou Biosciences.
- Bruce & Co added most to Caribou Biosciences in Q2 2023, an estimated $449K increase.
- Bruce & Co's biggest Q2 2023 reduction was Apple, cutting an estimated $871K.
- Bruce & Co's ten largest holdings make up 69% of its $356M portfolio in Q2 2023.
- Bruce & Co opened 0 new positions and closed 0 in Q2 2023.
- Bruce & Co's portfolio value fell 2.8% quarter-over-quarter to $356M.
Based on Bruce & Co's 13F filing for Q2 2023, filed 8 Aug 2023.